Back to Search Start Over

Temperature-sensitive heparin-modified poloxamer hydrogel with affinity to KGF facilitate the morphologic and functional recovery of the injured rat uterus.

Authors :
Xu, He-Lin
Xu, Jie
Zhang, Si-Si
Zhu, Qun-Yan
Jin, Bing-Hui
ZhuGe, De-Li
Shen, Bi-Xin
Wu, Xue-Qing
Xiao, Jian
Zhao, Ying-Zheng
Source :
Drug Delivery. 2017, Vol. 24 Issue 1, p867-881. 15p.
Publication Year :
2017

Abstract

Endometrial injury usually results in intrauterine adhesion (IUA), which is an important cause of infertility and recurrent miscarriage in reproductive women. There is still lack of an effective therapeutic strategy to prevent occurrence of IUA. Keratinocyte growth factor (KGF) is a potent repair factor for epithelial tissues. Here, a temperature-sensitive heparin-modified poloxamer (HP) hydrogel with affinity to KGF (KGF-HP) was used as a support matrix to prevent IUA and deliver KGF. The rheology of KGF-HP hydrogel was carefully characterized. The cold KGF-HP solution was rapidly transited to hydrogel with suitable storage modulus (G′) and loss modulus (G″) for the applications of uterus cavity at temperature of 33 °C.In vitrorelease demonstrated that KGF was released from HP hydrogels in sustained release manner for a long time.In vivobioluminescence imaging showed that KGF-HP hydrogel was able to prolong the retention of the encapsulated KGF in injured uterus of rat model. Moreover, the morphology and function of the injured uterus were significantly recovered after administration of KGF-HP hydrogel, which were evaluated by two-dimensional ultrasound imaging and receptive fertility. Not only proliferation of endometrial glandular epithelial cells and luminal epithelial cells but also angiogenesis of injured uterus were observed by Ki67 and CD31 staining after 7 d of treatment with KGF-HP hydrogel. Finally, a close relatively relationship between autophagy and proliferation of endometrial epithelial cells (EEC) and angiogenesis was firstly confirmed by detecting expression of LC3-II and P62 after KGF treatment. Overall, KGF-HP may be used as a promising candidate for IUA treatment. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
10717544
Volume :
24
Issue :
1
Database :
Academic Search Index
Journal :
Drug Delivery
Publication Type :
Academic Journal
Accession number :
126591095
Full Text :
https://doi.org/10.1080/10717544.2017.1333173